Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
Venetoclax and hypomethylating agents in acute myeloid leukemia: Mayo Clinic series on 86 patients
Morsia, Erika, McCullough, Kristen, Joshi, Maansi, Cook, Joselle, Alkhateeb, Hassan B., Al‐Kali, Aref, Begna, Kebede, Elliott, Michelle, Hogan, William, Litzow, Mark, Shah, Mithun, Pardanani, Animesh, Patnaik, Mrinal, Tefferi, Ayalew, Gangat, Naseema
Published in American journal of hematology (01.12.2020)
Published in American journal of hematology (01.12.2020)
Get full text
Journal Article
Sodium‐glucose co‐transporter‐2 inhibitor use and JAK2 unmutated erythrocytosis in 100 consecutive cases
Gangat, Naseema, Abdallah, Mostafa, Szuber, Natasha, Saliba, Antoine, Alkhateeb, Hassan, Al‐Kali, Aref, Begna, Kebede H., Pardanani, Animesh, Tefferi, Ayalew
Published in American journal of hematology (01.07.2023)
Published in American journal of hematology (01.07.2023)
Get full text
Journal Article
Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients
Gangat, Naseema, Karrar, Omer, Iftikhar, Moazah, McCullough, Kristen, Johnson, Isla M., Abdelmagid, Maymona, Abdallah, Mostafa, Al‐Kali, Aref, Alkhateeb, Hassan B., Begna, Kebede H., Mangaonkar, Abhishek, Saliba, Antoine N., Hefazi Torghabeh, Mehrdad, Litzow, Mark R., Hogan, William, Shah, Mithun, Patnaik, Mrinal M., Pardanani, Animesh, Badar, Talha, Murthy, Hemant, Foran, James, Palmer, Jeanne, Sproat, Lisa, Khera, Nandita, Arana Yi, Cecilia, Tefferi, Ayalew
Published in American journal of hematology (01.02.2024)
Published in American journal of hematology (01.02.2024)
Get full text
Journal Article
Venetoclax with azacitidine or decitabine in blast‐phase myeloproliferative neoplasm: A multicenter series of 32 consecutive cases
Gangat, Naseema, Guglielmelli, Paola, Szuber, Natasha, Begna, Kebede H., Patnaik, Mrinal M., Litzow, Mark R., Al‐Kali, Aref, Foran, James M., Palmer, Jeanne M., Alkhateeb, Hassan, Elliott, Michelle A., Hanson, Curtis A., Pardanani, Animesh, Mannelli, Francesco, Vannucchi, Alessandro M., Tefferi, Ayalew
Published in American journal of hematology (01.07.2021)
Published in American journal of hematology (01.07.2021)
Get full text
Journal Article
Phase 1/1b study of azacitidine and hedgehog pathway inhibitor sonidegib in patients with myeloid neoplasms
Tibes, Raoul, Kosiorek, Heidi E., Dueck, Amylou C., Palmer, Jeanne, Sproat, Lisa, Bogenberger, James, Hashmi, Shahrukh, Mesa, Ruben, Hogan, William, Litzow, Mark R., Al‐Kali, Aref
Published in Cancer (01.08.2023)
Published in Cancer (01.08.2023)
Get full text
Journal Article
Venetoclax plus hypomethylating agents in DDX41 ‐mutated acute myeloid leukaemia and myelodysplastic syndrome: Mayo Clinic series on 12 patients
Nanaa, Ahmad, He, Rong, Foran, James M., Badar, Talha, Gangat, Naseema, Pardanani, Animesh, Hogan, William J., Litzow, Mark R., Patnaik, Mrinal, Al‐Kali, Aref, Alkhateeb, Hassan B.
Published in British journal of haematology (01.01.2024)
Published in British journal of haematology (01.01.2024)
Get full text
Journal Article
Activity of the oral mitogen‐activated protein kinase kinase inhibitor trametinib in RAS‐mutant relapsed or refractory myeloid malignancies
Borthakur, Gautam, Popplewell, Leslie, Boyiadzis, Michael, Foran, James, Platzbecker, Uwe, Vey, Norbert, Walter, Roland B., Olin, Rebecca, Raza, Azra, Giagounidis, Aristoteles, Al‐Kali, Aref, Jabbour, Elias, Kadia, Tapan, Garcia‐Manero, Guillermo, Bauman, John W., Wu, Yuehui, Liu, Yuan, Schramek, Dan, Cox, Donna S., Wissel, Paul, Kantarjian, Hagop
Published in Cancer (15.06.2016)
Published in Cancer (15.06.2016)
Get full text
Journal Article
Suboptimal response rates to hypomethylating agent therapy in chronic myelomonocytic leukemia; a single institutional study of 121 patients
Coston, Tucker, Pophali, Prateek, Vallapureddy, Rangit, Lasho, Terra L., Finke, Christy M., Ketterling, Rhett P., Carr, Ryan, Binder, Moritz, Mangaonkar, Abhishek A., Gangat, Naseema, Al‐Kali, Aref, Litzow, Mark, Zblewski, Darci, Pardanani, Animesh, Tefferi, Ayalew, Patnaik, Mrinal M.
Published in American journal of hematology (01.07.2019)
Published in American journal of hematology (01.07.2019)
Get full text
Journal Article
Cardiac events in newly diagnosed acute myeloid leukaemia during treatment with venetoclax + hypomethylating agents
Johnson, Isla M., Karrar, Omer, Rana, Masooma, Iftikhar, Moazah, Chen, Sunny, McCullough, Kristen, Saliba, Antoine N., Al‐Kali, Aref, Alkhateeb, Hassan, Begna, Kebede, Litzow, Mark, Hogan, William J., Shah, Mithun, Patnaik, Mrinal M., Pardanani, Animesh, Hermann, Joerg, Tefferi, Ayalew, Gangat, Naseema
Published in British journal of haematology (01.04.2024)
Published in British journal of haematology (01.04.2024)
Get full text
Journal Article
Venetoclax and hypomethylating agents in older/unfit patients with blastic plasmacytoid dendritic cell neoplasm
Gangat, Naseema, Konopleva, Marina, Patnaik, Mrinal M., Jabbour, Elias, DiNardo, Courtney, Al‐Kali, Aref, Foran, James M., Granroth, Ginna L., Olteanu, Horatiu, Kadia, Tapan, Tefferi, Ayalew, Pemmaraju, Naveen
Published in American journal of hematology (01.02.2022)
Published in American journal of hematology (01.02.2022)
Get full text
Journal Article
Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival
Karrar, Omer, Abdelmagid, Maymona, Rana, Masooma, Iftikhar, Moazah, McCullough, Kristen, Al‐Kali, Aref, Alkhateeb, Hassan B., Begna, Kebede H., Elliott, Michelle A., Mangaonkar, Abhishek, Saliba, Antoine, Hefazi Torghabeh, Mehrdad, Litzow, Mark R., Hogan, William, Shah, Mithun, Patnaik, Mrinal M., Pardanani, Animesh, Badar, Talha, Murthy, Hemant, Foran, James, Palmer, Jeanne, Sproat, Lisa, Khera, Nandita, Arana Yi, Cecilia, Tefferi, Ayalew, Gangat, Naseema
Published in American journal of hematology (01.02.2024)
Published in American journal of hematology (01.02.2024)
Get full text
Journal Article
Granularity in disease classification impacts survival prediction in advanced systemic mastocytosis: A single institution study of 329 informative cases
Tefferi, Ayalew, Abdelmagid, Maymona, Al‐Kali, Aref, Patnaik, Mrinal, Hogan, William J., Begna, Kebede, Gangat, Naseema, Orazi, Attilio, Chen, Dong, Reichard, Kaaren K., Pardanani, Animesh
Published in American journal of hematology (01.01.2024)
Published in American journal of hematology (01.01.2024)
Get full text
Journal Article
Cladribine therapy for advanced and indolent systemic mastocytosis: Mayo Clinic experience in 42 consecutive cases
Tefferi, Ayalew, Kittur, Jaya, Farrukh, Faiqa, Begna, Kebede H., Patnaik, Mrinal M., Al‐Kali, Aref, Elliott, Michelle A., Reichard, Kaaren K., Gangat, Naseema, Pardanani, Animesh
Published in British journal of haematology (01.02.2022)
Published in British journal of haematology (01.02.2022)
Get full text
Journal Article
Prevalence of cytopenia(s) and somatic variants in patients with DDX41 mutant germline predisposition syndrome
Kusne, Yael, Badar, Talha, Lasho, Terra, Marando, Ludovica, Mangaonkar, Abhishek A., Finke, Christy, Foran, James M., Al‐Kali, Aref, Palmer, Jeanne, Arana Yi, Cecilia, Alkhateeb, Hassan B., Gangat, Naseema, Viswanatha, David, Litzow, Mark R., Chlon, Timothy, Ferrer, Alejandro, Patnaik, Mrinal M.
Published in British journal of haematology (01.04.2025)
Published in British journal of haematology (01.04.2025)
Get full text
Journal Article
Gilteritinib clinical activity in relapsed/refractory FLT3 mutated acute myeloid leukemia previously treated with FLT3 inhibitors
Numan, Yazan, Abdel Rahman, Zaid, Grenet, Justin, Boisclair, Stephanie, Bewersdorf, Jan Philipp, Collins, Cailin, Barth, Dylan, Fraga, Martina, Bixby, Dale L., Zeidan, Amer M., Yilmaz, Musa, Desai, Pankil, Mannis, Gabriel, Deutsch, Yehuda E., Abaza, Yasmin, Dinner, Shira, Frankfurt, Olga, Litzow, Mark, Al‐Kali, Aref, Foran, James M., Sproat, Lisa Z., Jovanovic, Borko, Daver, Naval, Perl, Alexander E., Altman, Jessica K.
Published in American journal of hematology (01.03.2022)
Published in American journal of hematology (01.03.2022)
Get full text
Journal Article
Limited activity of luspatercept in myelofibrosis and myeloid neoplasms other than myelodysplastic syndromes with ring sideroblasts
Gangat, Naseema, Chetram, Deandra, McCullough, Kristen, Al‐Kali, Aref, Begna, Kebede, Hogan, William, Litzow, Mark, Foran, James, Badar, Talha, Palmer, Jeanne, Patnaik, Mrinal, Pardanani, Animesh, Tefferi, Ayalew
Published in American journal of hematology (01.12.2022)
Published in American journal of hematology (01.12.2022)
Get full text
Journal Article
Real‐world experience with luspatercept and predictors of response in myelodysplastic syndromes with ring sideroblasts
Farrukh, Faiqa, Chetram, Deandra, Al‐Kali, Aref, Foran, James, Patnaik, Mrinal, Badar, Talha, Begna, Kebede, Hook, Christopher, Hogan, William, McCullough, Kristen B., Mangaonkar, Abhishek, He, Rong, Gangat, Naseema, Tefferi, Ayalew
Published in American journal of hematology (01.06.2022)
Published in American journal of hematology (01.06.2022)
Get full text
Journal Article
Spectrum of renal pathological findings in patients with chronic myelomonocytic leukemia and kidney injury
Gipe, Nate, Leung, Nelson, Lasho, Terra, Mangaonkar, Abhishek, Alkhateeb, Hassan, Al‐Kali, Aref, Gangat, Naseema, Hogan, William, McCullough, Kristen, Tefferi, Ayalew, Alexander, Mariam Priya, Patnaik, Mrinal M.
Published in American journal of hematology (01.06.2023)
Published in American journal of hematology (01.06.2023)
Get full text
Journal Article
Momelotinib for myelofibrosis: 12‐year survival data and retrospective comparison to ruxolitinib
Tefferi, Ayalew, Pardanani, Animesh, Begna, Kebede H., Al‐Kali, Aref, Hogan, William J., Litzow, Mark R., Hanson, Curtis A., Ketterling, Rhett P., Gangat, Naseema
Published in American journal of hematology (01.12.2022)
Published in American journal of hematology (01.12.2022)
Get full text
Journal Article